SMS Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE812G01025
  • NSEID: SMSPHARMA
  • BSEID: 532815
INR
473.65
-8.7 (-1.8%)
BSENSE

Nov 20

BSE+NSE Vol: 2.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
9.37
8.87
8.47
8.47
8.47
8.47
Share Warrants & Outstandings
Total Reserve
776.44
614.90
499.29
452.06
461.82
402.06
Shareholder's Funds
785.81
639.64
536.33
460.53
470.29
410.53
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
171.64
139.36
122.09
158.72
149.50
147.41
Secured Loans
170.44
138.16
120.89
157.52
148.30
146.21
Unsecured Loans
1.20
1.20
1.20
1.20
1.20
1.20
Deferred Tax Assets / Liabilities
50.82
48.10
42.80
41.02
39.55
53.85
Other Long Term Liabilities
0
0
0
0.61
2.11
3.15
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.20
1.21
1.16
1.40
1.57
1.84
Total Non-Current Liabilities
223.65
188.67
166.05
164.17
192.73
206.26
Current Liabilities
Trade Payables
120.43
113.92
151.32
107.43
72.86
65.44
Other Current Liabilities
38.21
37.95
21.27
15.06
11.99
26.06
Short Term Borrowings
193.41
171.39
158.09
131.38
110.61
103.11
Short Term Provisions
0.92
1.11
1.03
1.04
1.02
0.82
Total Current Liabilities
352.98
324.37
331.72
254.91
196.48
195.43
Total Liabilities
1,362.44
1,152.68
1,034.09
879.61
859.50
812.21
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
800.87
759.92
630.20
573.86
567.07
554.34
Less: Accumulated Depreciation
266.86
226.94
193.35
162.90
131.63
100.48
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
534.01
532.98
436.85
410.97
435.44
453.86
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
121.64
34.67
30.27
33.19
11.00
6.74
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
26.28
11.68
10.94
10.52
21.53
27.30
Long Term Loans & Advances
38.53
15.94
19.04
10.70
9.32
9.10
Other Non Current Assets
3.96
2.95
2.69
2.54
2.61
2.38
Total Non-Current Assets
724.43
598.21
500.20
468.96
482.45
502.88
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
351.21
284.73
233.70
223.50
251.10
137.79
Sundry Debtors
215.87
203.23
236.23
148.35
48.52
105.68
Cash and Bank
46.07
41.59
36.20
7.47
46.66
40.51
Other Current Assets
19.62
22.23
18.46
27.43
25.97
22.17
Short Term Loans and Advances
5.24
2.69
9.30
3.90
4.81
3.18
Total Current Assets
638.01
554.47
533.89
410.65
377.05
309.33
Net Current Assets (Including Current Investments)
285.03
230.10
202.18
155.74
180.57
113.90
Total Current Assets Excluding Current Investments
638.01
554.47
533.89
410.65
377.05
309.33
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,362.44
1,152.68
1,034.09
879.61
859.50
812.21
Contingent Liabilities
56.89
56.62
5.67
2.75
8.12
7.01
Total Debt
365.05
310.76
280.18
252.51
260.11
250.52
Book Value per share (adjusted)
83.91
70.36
59.98
54.4
55.56
48.5
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 17.47% vs 10.91% in Mar 2025

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 15.50% vs 21.52% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 125.00% vs 6.76% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 15.07% vs 3.85% in Mar 2025

Compare Balance Sheet Results of SMS Pharma.
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.37
34.63
-25.26
-72.94%
Share Warrants & Outstandings
Total Reserve
776.44
658.86
117.58
17.85%
Shareholder's Funds
785.81
693.49
92.32
13.31%
Minority Interest
0.00
2.68
-2.68
-100.00%
Long-Term Borrowings
171.64
6.37
165.27
2,594.51%
Secured Loans
170.44
0.00
170.44
0.00%
Unsecured Loans
1.20
6.37
-5.17
-81.16%
Deferred Tax Assets / Liabilities
50.82
-25.26
76.08
301.19%
Other Long Term Liabilities
0.00
183.58
-183.58
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.20
7.66
-6.46
-84.33%
Total Non-Current Liabilities
223.65
172.35
51.30
29.77%
Current Liabilities
Trade Payables
120.43
104.60
15.83
15.13%
Other Current Liabilities
38.21
70.14
-31.93
-45.52%
Short Term Borrowings
193.41
22.36
171.05
764.98%
Short Term Provisions
0.92
40.18
-39.26
-97.71%
Total Current Liabilities
352.98
237.27
115.71
48.77%
Total Liabilities
1,362.44
1,105.79
256.65
23.21%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
800.87
214.21
586.66
273.87%
Less: Accumulated Depreciation
266.86
69.46
197.40
284.19%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
534.01
144.75
389.26
268.92%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
121.64
1.71
119.93
7,013.45%
Intangible assets under development
0.00
13.75
-13.75
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
26.28
263.88
-237.60
-90.04%
Long Term Loans & Advances
38.53
0.16
38.37
23,981.25%
Other Non Current Assets
3.96
0.00
3.96
0.00%
Total Non-Current Assets
724.43
648.62
75.81
11.69%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
351.21
192.64
158.57
82.31%
Sundry Debtors
215.87
73.52
142.35
193.62%
Cash and Bank
46.07
95.57
-49.50
-51.79%
Other Current Assets
19.62
20.58
-0.96
-4.66%
Short Term Loans and Advances
5.24
74.86
-69.62
-93.00%
Total Current Assets
638.01
457.17
180.84
39.56%
Net Current Assets (Including Current Investments)
285.03
219.89
65.14
29.62%
Total Current Assets Excluding Current Investments
638.01
457.17
180.84
39.56%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,362.44
1,105.79
256.65
23.21%
Contingent Liabilities
56.89
0.00
56.89
0.00%
Total Debt
365.05
0.00
365.05
0.00%
Book Value per share (adjusted)
83.91
200.24
-116.33
-58.10%
Annual - Borrowings
Borrowings 365.05 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.47% vs 10.91% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 655.65 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 15.50% vs 21.52% in Mar 2025

Annual - Investments
Investments 26.28 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 125.00% vs 6.76% in Mar 2025

Annual - Current Assets
Current Assets 638.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 15.07% vs 3.85% in Mar 2025